Market Newsdesk

SOUTHFIELD, Mich., March 15, 2021 (GLOBE NEWSWIRE) — DENSO, a leading mobility supplier, was ranked 36th in Harrity Patent Analytics’ 2021 Patent 300® List. Despite a global pandemic, DENSO increased the number of patents it secured year-over-year, a testament to its focus on creating technologies that are green, meaning environmentally friendly, and deliver peace of mind, meaning safety for all.

The Patent 300 is an annual compilation of the top 300 companies, organizations and universities in the patent field. It is based on the quantity of issued U.S. patents each year. DENSO’s rise within the list signals the company’s global commitment to research and development (R&D), electrification, connectivity and other new and innovative mobility solutions that will make for a safer and more sustainable world.

“We are thrilled to be recognized among such an esteemed list of innovators and creators,” said Shinichiro Nakamura, a senior vice president of DENSO’s North American R&D. “The past year has been challenging, but with a focus on quality, collaboration and resiliency, we have continued to develop leading technologies that will better serve our customers and enhance mobility.”

Achieving such an honor would not be possible without DENSO’s expansive R&D network, which includes R&D teams and centers located around the world. DENSO R&D centers are located in Pittsburgh; Seattle; San Jose, California; Plano, Texas; Montréal, Canada; Israel; and Finland.  

These centers work with teams in Japan, Michigan and elsewhere to research critical mobility fields like automated driving, artificial intelligence, cloud computing and software. Their collective work advances DENSO’s Second Founding and long-term plan, both of which center on creating new value for society and customers.

If you are interested in joining a team committed to transforming mobility and careers, visit https://densocareers.com/.

The complete breakdown of the 2021 Patent 300 List is available online here.

About DENSO

DENSO is a $47.6 billion global mobility supplier that develops advanced technology and components for nearly every vehicle make and model on the road today. With manufacturing at its core, DENSO invests in its 200 facilities to produce thermal, powertrain, mobility, electrification, & electronic systems, to create jobs that directly change how the world moves. The company’s 170,000+ employees are paving the way to a mobility future that improves lives, eliminates traffic accidents, and preserves the environment. Globally headquartered in Kariya, Japan, DENSO spent 9.9 percent of its global consolidated sales on research and development in the fiscal year ending March 31, 2020. For more information about global DENSO, visit https://www.denso.com/global.

In North America, DENSO is headquartered in Southfield, Michigan, and employs 27,000+ engineers, researchers and skilled workers across 51 sites in the U.S, Canada and Mexico. In the United States alone, DENSO employs 17,700+ employees across 14 states (and the District of Columbia) and 41 sites. In fiscal year ending March 31, 2020, DENSO in North America generated $10.9 billion in consolidated sales. DENSO is committed to advancing diversity and inclusion inside the company and beyond – a principle that brings unique perspectives together, bolsters innovation and pushes DENSO forward. Join us, and craft not only how the world moves, but also your career: densocareers.com. For more information, go to https://www.denso.com/us-ca/en/.

Contact: Andrew Rickerman DENSO International America, Inc.  (734) 560-8752 [email protected]

Vaughan, March 15, 2021 (GLOBE NEWSWIRE) — Construction of much-needed new housing throughout the GTA is being delayed because Local 183 of the Labourers International Union of North America is preventing bricklayers from working for builders, despite a ruling handed down by the Ontario Labour Relations Board (OLRB).

This is all being done in an attempt to organize or interfere with stucco/EIFS contractors, who are represented by a rival trade union.

“This is happening at a time when the industry has been declared an essential service by government and we are struggling to keep pace with the demand for new housing in the face of COVID-19-related challenges,” says Richard Lyall, president of the Residential Construction Council of Ontario (RESCON). “As a result of the union’s illegal actions, thousands of homes will not be completed on time.”

On March 4, the OLRB ruled that Local 183 threatened an unlawful strike and committed acts that would lead bricklayers to engage in an unlawful strike, by illegally threatening builders with removing bricklayers from jobsites if they contracted stucco contractors not bound to a Local 183 collective agreement. Builders have no obligation to use a Local 183 stucco contractor to complete their houses. The union was ordered to cease and desist from such activities and post a copy of the board’s declarations on relevant notice boards, its website, notify builders and contractors directly or post in the Daily Commercial News.

The ruling was made in an unlawful strike application filed by the Toronto Residential Construction Labour Bureau (TRCLB) against Local 183 and the Masonry Contractors’ Association of Toronto.

However, Local 183 continues to disrupt the industry and not allow bricklaying contractors to perform work for builders if there is a non-Local 183 contractor on site. The union’s actions have forced delays in housing completions, preventing workers from earning a living. Delayed home closings are causing hardship for homebuyers. They need their new home as shelter for their families.

“The actions of Local 183 are very disturbing and selfish, given the negative impact on homebuyers and workers within the residential construction industry,” says Ron Johnson, executive director of the Interior Systems Contractors Association (ISCA). “Local 183’s continued actions contravene the OLRB’s order and continue to negatively affect homebuyers.”

Gary Campacci, president and one of the owners of Woodbridge, Ont.-based DuROCK Alfacing International Ltd., which manufactures exterior insulation finish systems (EIFS), says the union has stopped work for EIFS and masonry contractors despite the ruling.

“This has resulted in essential workers not being able to go to work to support their families,” he says. “After months of litigation, there are many builders still not able to complete their homes, resulting in closing delays.” All this, even though the labour board has already ruled the union’s activities are illegal.

The dispute comes at a time when Ontario is in the midst of a housing shortage and builders are trying to make up for lost time while dealing with COVID-19. Reports suggest the industry needs to build 75,000 new homes per year over the next 24 years just to keep up with demand, but is short 12,000 units per year.

“Contractors continue to build much-needed housing during this pandemic, but Local 183 is now throwing a wrench into the works,” states Michael DeGasperis, president and CEO of Arista Homes. “The actions by Local 183 are shameful acts of unlawful intimidation and interference without apparent regard to the thousands of new home buyers affected by late closings.”

Local 183 must stop interfering and delaying the construction of new homes and abide by the OLRB ruling.

Background on RESCON:

RESCON is the province’s leading association of residential builders committed to providing leadership and fostering innovation in the industry.

Attachment

• Decision – March 04, 2021

Grant Cameron
RESCON - senior director of public affairs
905-638-1706
[email protected]

• A record high of 1,268 total Microsoft vulnerabilities were discovered in 2020, with “Elevation of Privilege” as the #1 vulnerability category
• Report finds that removing admin rights from endpoints would mitigate 56% of all Critical Microsoft vulnerabilities from 2020

ATLANTA, March 15, 2021 (GLOBE NEWSWIRE) — BeyondTrust, the worldwide technology leader in Privileged Access Management, today announced the release of the 2021 Microsoft Vulnerabilities Report. The research includes the latest annual breakdown of Microsoft vulnerabilities by category and product, as well as a five-year trend analysis, providing a holistic understanding of the evolving threat landscape. The BeyondTrust Microsoft Vulnerabilities Report, produced annually by BeyondTrust, analyzes the data from security bulletins publicly issued by Microsoft throughout the previous year.

Approximately 1.5 billion people use Windows operating systems each day, with various applications for Microsoft’s products reaching into homes, businesses, and entertainment venues. The data in this report provides a crucial barometer of the threat landscape for the Microsoft ecosystem.

Now in its eighth edition, this year’s report identified the following highlights:

• In 2020, a record-high number of 1,268 Microsoft vulnerabilities were discovered, a 48% increase YoY
• The number of reported vulnerabilities has risen an astonishing 181% in the last five years (2016-2020)
• Removing admin rights from endpoints would mitigate 56% of all Critical Microsoft vulnerabilities in 2020
• For the first time, “Elevation of Privilege” was the #1 vulnerability category, comprising 44% of the total, nearly three times more than in the previous year
• 87% of Critical vulnerabilities in Internet Explorer and Microsoft Edge would have been mitigated by removing admin rights
• 70% of Critical vulnerabilities affecting Windows 7, Windows RT, 8/8.1 and 10 would have been mitigated by removing admin rights
• 80% of Critical vulnerabilities in all Office products (Excel, Word, PowerPoint, Visio, Publisher, and others) would have been mitigated by removing admin rights
• 66% of Critical vulnerabilities affecting Windows Servers would have been mitigated by removing admin rights

“To adjust to the new work-from-home realities, companies need to better manage the proliferation of desktop and mobile devices, including applying patches and security updates,” said Chuck Brooks, a cybersecurity expert and faculty member at Georgetown University. “Controlling user privileges and employing stronger endpoint management under a Zero Trust framework are prudent initiatives for companies to follow as digital connectivity grows.”

“The sheer fact that patching must always occur is a cyber security basic, said Morey Haber, Chief Technology Officer & Chief Information Security Officer at BeyondTrust. “However, deflecting an attack with good cyber security policies like the removal of administrative rights ultimately makes the environment, and home workers, even more secure. And, most importantly, honoring least privilege can buy your organization time to patch when critical vulnerabilities are published.”

With the surge in Microsoft vulnerabilities, ensuring the endpoints in your organization are secured is more critical than ever. The removal of administrative rights is critical to mitigating the risks outlined in this report. BeyondTrust Endpoint Privilege Management enables organizations to achieve least privilege with a solution that not only deploys quickly, but also strikes the right balance between security and productivity.

The 2021 Microsoft Vulnerabilities Report can be downloaded here: https://www.beyondtrust.com/resources/whitepapers/microsoft-vulnerability-report

About BeyondTrust

BeyondTrust is the worldwide leader in Privileged Access Management (PAM), empowering organizations to secure and manage their entire universe of privileges. Our integrated products and platform offer the industry’s most advanced PAM solution, enabling organizations to quickly shrink their attack surface across traditional, cloud and hybrid environments.

The BeyondTrust Universal Privilege Management approach secures and protects privileges across passwords, endpoints, and access, giving organizations the visibility and control they need to reduce risk, achieve compliance, and boost operational performance. We are trusted by 20,000 customers, including 70 percent of the Fortune 500, and a global partner network. Learn more at www.beyondtrust.com.

Follow BeyondTrust
:

Twitter: http://twitter.com/beyondtrust
Blog: https://www.beyondtrust.com/blog
LinkedIn: http://www.linkedin.com/companies/beyondtrust
Facebook: http://www.facebook.com/beyondtrust

For BeyondTrust:

Mike Bradshaw
Connect Marketing for BeyondTrust
P: (801) 373-7888
E: [email protected]

BOURNEMOUTH, England, March 15, 2021 (GLOBE NEWSWIRE) — In a flurry of lust mistaken for love with an international criminal, all bets on a safe, happy life are off. As the sequel to her book, “Burning Desire,” author M. L. Stark recently published “Burning Desire Fades: The Psychopath and the Girl in Black Prada Shoes.” Stark shares her life events in a thrilling fiction story that follows the main character, Mary, as her chase for love engulfs her. She sacrifices her livelihood for toxic adventures with Doctor Drake Lucifer Bates that take them across the globe.

In “Burning Desire,” Mary’s toxic love story with Doctor Bates begins. Now, in “Burning Desire Fades,” Mary is plagued with his constant deceit, abuse and lies as she and Drake bolt from country to country after his schemes and scams catch up to him. Financially bailing him out of messes, lying on his behalf, leaving her children behind and putting her life on the line for their future eventually catches up to Mary, and she must make the difficult decision to lose herself completely in love or leave him behind.

In a book review, Ramona Portelli expands on the thrilling nature of this story: “This book really kept me hooked on, turning from one page to another until I read it all.  Well done to Author M.L. Stark who managed to plot all the story in this wonderful book.  I really recommend Burning Desire Fades – The Psychopath and the Girl in Black Prada Shoes Part 2.”

Stark’s writing sheds light on psychological abuse and increases awareness of fake adoration, scammers and sociopaths. In this tale of the double-edged sword of love, readers will find the line between love and manipulation is anything but clear-cut.

“We need more awareness about the blindness in adoration and the fake love scammers and sociopaths use to mentally abuse others,” said Stark. “Living with a narcissist and a manipulative person is more than difficult to get through. My narcissist was not a monster or an evil creature, but he had a cruel agenda for me.”

At the end of the novel, Stark touches on relevant topics today such as cyberbullying and the COVID-19 pandemic. She is sharing her story to relate to women and men who are or have been in a toxic relationship. Stark hopes to bring awareness to emotional abuse and help readers decipher the red flags of an abusive partner before losing themselves in a false idea of love.

“
Burning Desire Fades: The Psychopath and the Girl in Black Prada Shoes”


By M. L. Stark
ISBN: 978-1-6641-1258-2 (softcover); 978-1-6641-1259-9 (hardcover); 978-1-6641-1257-5 (e-book)
Available at the Xlibris Online Bookstore, Amazon and Barnes & Noble.  

About the author

M. L. Stark wrote the “Burning Desire” series based on experiences from her personal life. After a marriage of over 20 years, she was divorced and met a new man that mentally abused her and is now reflecting on that entire experience. In 2014, Stark began to research sociopathic behavior and along with her first-hand experience dating a psychopathic man, she began to write her story in 2016. By sharing her real-life events in a fictionalized account, Stark hopes to connect with people and deter them from facing a toxic relationship in their lives. Currently, Stark resides in Bournemouth, Dorset. Please visit Stark’s author website: https://www.ml-stark.com/.

About XlibrisUK

Xlibris Publishing UK, an Author Solutions, LLC imprint, is a self-publishing services provider dedicated to serving authors throughout the United Kingdom. By focusing on the needs of creative writers and artists and adopting the latest print-on-demand publishing technology and strategies, we provide expert publishing services with direct and personal access to quality publication in hardcover, trade paperback, custom leather-bound and full-color formats. To date, Xlibris has helped to publish more than 60,000 titles. For more information, visit xlibrispublishing.co.uk or call 0800 056 3182 to receive a free publishing guide.

Attachment

• 805069HighRes

Krista Tillman
LAVIDGE Publicity
4806487560
[email protected]

RENSSELAER, N.Y., March 15, 2021 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces Monica Gostissa, PhD, has joined its Scientific Advisory Board (SAB). Dr. Gostissa joins existing board members, Frank Sistare, PhD; Andrew Goodman, PhD; David Hill, PhD; and Robert Rosenthal, PhD.

The SAB collaborates with Taconic management, providing scientific insight and guidance to expand the company’s product and service portfolio. Dr. Gostissa’s extensive career in the immunology and immuno-oncology fields brings new expertise to the board and complements Taconic’s leadership in these research areas.

The SAB members’ expertise in microbiome, oncology, neurobiology, and toxicology spaces mirror Taconic’s focus on innovation in these research areas.

“Immunology and immuno-oncology represent areas of thriving research and focus for Taconic. We welcome Dr. Gostissa to our team. She will provide valuable expertise and direction as Taconic continues developing the best animal model solutions to inform human clinical outcomes,” shared Nancy J. Sandy, Taconic Biosciences chief executive officer.

Dr. Monica Gostissa is the Senior Director of In vivo and Ex vivo Sciences at Jounce Therapeutics, where she leads a multidisciplinary team with capabilities spanning in vivo pharmacology, ex-vivo 3D model development, and histopathology. During her 20-year career in basic research, Dr. Gostissa obtained extensive expertise in developing and interrogating complex mouse models of hematological and solid malignancies. She also has deep cell biology and tumor immunology knowledge. Since 2014, Dr. Gostissa has led preclinical programs at small and large biotech companies, focusing on best translating scientific insights into innovative cancer therapeutics.

Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy, and completed post-doctoral studies at Boston Children’s Hospital/Harvard Medical School. She co-authored over 40 peer-reviewed publications and was the recipient of several awards, including a Leukemia and Lymphoma Society Special Fellow Award and a V Foundation Scholar Award.

Please find information on Taconic’s additional SAB members below:

Dr. Andrew Goodman is an associate professor of microbial pathogenesis and a member of the Microbial Sciences Institute at Yale University School of Medicine. Dr. Goodman has been recognized with the NIH Director’s New Innovator Award, the Pew Scholars Fellowship, DuPont Young Professor Award, Burroughs Wellcome Fund Investigator Award, Howard Hughes Medical Institute Faculty Scholar Award, and the Presidential Early Career Award in Science and Engineering. Dr. Goodman’s research focuses on understanding interaction between members of the human gut microbiome and with the host. The Goodman lab combines microbial genetics, gnotobiotic animal models, and computational approaches to develop new technologies for studying the microbiome and to apply them to uncover the causes and consequences of interpersonal microbiome variation. Dr. Goodman was trained in ecology and evolutionary biology at Princeton University and completed his PhD in microbiology at Harvard Medical School.

Dr. David Hill has established a successful and extensive career leading the pharmacology departments at many major pharmaceutical companies, including a combined twenty years at Organon and Merck. Dr. Hill’s therapeutic expertise includes neuroscience, pain, anesthesia, cardiometabolic disease, and oncology. Dr. Hill played a pivotal role in directing preclinical animal model programs of various sizes that resulted in many new therapeutics. Beyond his scientific expertise, Dr. Hill also brings a keen knowledge of harmonizing internal and outsourced resources to produce both sound scientific and business results. Dr. Hill earned a BS degree in applied biology from Hatfield Polytechnic and PhD in pharmacology from St. Thomas Hospital Medical School.

Dr. Robert J. Rosenthal has more than 30 years of experience relating to companies involved in the development of diagnostics, therapeutics, medical devices, and life sciences tools. He currently serves on the Safeguard Scientifics, Inc. Board of Directors, where he is Chairman of the Capital Management Committee and a member of the Audit and Compensation Committees. Prior to Taconic, Bob’s executive leadership roles include; Chairman of the Board and Chief Executive Officer of IMI Intelligent Medical Implants AG, a medical technology company that developed a retinal implant system for degenerative disorders; and President, Chief Executive Officer and a Director of Magellan Biosciences, Inc., a provider of life sciences research tools, which he founded. Bob holds a BS degree from the University of Maryland, an MS from State University of New York, a PhD from Emory University, and an Executive MBA from Stanford University. He completed a post-doctoral fellowship at Universität Würzburg, Germany, as a guest scientist of the Alexander von Humboldt Foundation, followed by an additional post-doctoral fellowship at UCLA.

About Taconic Biosciences, Inc.

Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions so that customers can acquire, custom-generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, microbiome, immuno-oncology mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.

Media Contact:

Kelly Owen Grover

Director of Marketing Communications

518-478-6095

[email protected]

MORRISVILLE, N.C., March 15, 2021 (GLOBE NEWSWIRE) — Syneos Health Communications – the portfolio of Syneos Health^® agencies designed to deliver insights-driven integrated communications spanning advertising, public relations, patient advocacy, medical communications, managed markets, omnichannel, naming and branding – has added seasoned global talent to lead creative expression and strategy in communications that drive positive health outcomes.  

Syneos Health Communications, including the market-leading healthcare advertising agency GSW, translates complex information into clear, actionable solutions to enable audiences to make informed, confident decisions. These health-first, health-only agencies deploy a wide array of strategic capabilities, with a direct line to 25,000 Syneos Health clinical and commercial minds, to bring breakthrough healthcare to the world.

“From launching a new treatment in a crowded space, to rethinking how a treatment can target a new audience, we weave together the power of technology, communications and humanity,” said JD Cassidy, President, Advertising, for Syneos Health Communications. “This new group of leaders includes some of the industry’s most creative minds, disrupters and change masters – skilled at breathing life into our customers’ innovations and our colleagues’ work – to make the strongest impact on the right audiences.”

Three senior hires joining Syneos Health Communications include:

Orrin Pollard, Director of European Creative Expression, has more than 25 years of experience leading creative teams across every therapeutic area in the health and wellness space. He was the founder and creative director of DDB Remedy UK, and has created and inspired numerous multi-award-winning national OTC and global ethical campaigns across Europe. Orrin has served as a judge on many international awards panels including Cannes Lions, Clio Health & Eurobest, and his work has been recognized by Cannes Lions, Clio Health, D&AD, LIAA, PM Society Digital Awards and The Globals, among others.

Christina Pantelias, EVP of Strategy, GSW New York, is an executive leader with decades of experience turning information into insights that build brands. She is passionate about the theory and practice of connecting people with brands and is known for building high-performing teams. She previously ran Strategic Planning for Arnold’s DC and St. Louis offices, and has worked on a wide range of categories and blue chip brands including Kellogg’s, Johnson & Johnson, Merck, P&G, and Novo Nordisk, among others.

Carolyn Gargano,
SVP, Creative Director, GSW West Coast, joins with over 20 years of experience in the health and wellness space, partnering with clients across a deep roster of domestic and global brands. She will lead agency-wide initiatives that champion creativity, with a passion for social purpose campaigns that make the world a healthier place. She previously held roles at W2O, Area 23, Saatchi & Saatchi Wellness, FCB and Deutsch, in addition to Chandler Chicco Agency, a Syneos Health Communications agency.

This new trio of creative leaders will work across Syneos Health Communications to bring science to life in service of the healthcare industry, scientists, clinicians, manufacturers and patients. They’ll provide a clear, definitive, and persuasive voice to accelerate research and innovation to improve the health and well-being of society.

Syneos Health Communications agencies work in scalable, purpose-built teams that partner across disciplines and geographies to accelerate brand performance. The portfolio includes GSW, GSW Managed Markets, Chandler Chicco Agency, Biosector 2, Chamberlain Healthcare Communications, Managed Markets Communications, Navicor, Cadent Medical Communications and Addison Whitney, among others.

About Syneos Health

Syneos Health^® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 25,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are Shortening the distance from lab to life^®, visit syneoshealth.com or subscribe to our podcast.

Investor Relations Contact: Ronnie Speight Senior Vice President, Investor Relations +1 919 745 2745 [email protected]

Press/Media Contact: Gary Gatyas Executive Director, External Communications +1 908 763 3428  [email protected]

MIRAMAR BEACH, FL, March 15, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — MasterBeatCorporation (OTC: MSTO), a company specializing in hard, tangible asset acquisitions with an intense focus on real estate, precious metals, collectible classic automobiles, and other tangible assets, announces the development of JTEC Auto World (www.jtecautoworld.com), new mobile application (or “app”) soon to be available for Apple devices running iOS from the platform’s App Store, and Android devices from the Google Play Store.

The application is expected to be available in the coming weeks and will feature all the same services offered by our browser-based website platform, which consolidates 3 segments of the automotive industry, combining New & Used Automobiles, New & Used Auto Parts and Accessories, and a Nationwide Automotive Technician Services Directory all under one application.

In 2020, digital influence impacted the US Auto Parts retail industry by over $140 billion. Digital influence is projected to reach $168 billion by 2023 in the United States.

Trends in online shopping have had a massive effect on the automotive industry, taking the auto parts eCommerce market share to over $16 billion in 2020. The US. Auto Parts eCommerce market share is projected to grow to over $22 billion by 2023.

“The Auto Parts eCommerce market share transactions are shifting to mobile use with mobile phones accounting for approximately $10.4 billion in the US in 2020. That is about a 40% increase over 2019,” stated Josh Tannariello, CEO of Masterbeat Corp.

“This is one of the fastest growing trends in online shopping and it will continue; Cell Phone sales will account for over $13 Billion in Auto Parts and Accessories sales for 2022. The Development of our mobile app is another step forward in streamlining the process for our customers’ experience shopping on our platform. The app gives us the ability to communicate with our users in a targeted fashion by sending out notifications that target the specific needs of our customers. We’ve found that more customers are expressing their preference to receive communications in ways the app allows us to via our notifications.

“Auto Parts is only one of the segments our online platform offers, the online new and used car sales industry is growing at an unprecedented rate and we plan on capturing market share via www.JTECAutoWorld.com The demand for Auto Technicians is at an all-time high and just like any industry the need to find a reputable service provider is paramount. Much like Angie’s List and Home Advisors helps homeowners find a qualified top rated professional, JTEC AutoWorld is dedicated in helping automotive owners find a qualified Auto Technician and Service Provider.”

ABOUT JTEC AUTOWORLD

NEW/USED CARS

JTEC Auto World’s “New and Used Car” online platform segment aims to provide, both to the buyer and seller, user-friendly tools necessary to significantly improve the car buying and selling experience with multiple listing options, including original and re-listing services, along with custom research options. The service is available to anyone by simply subscribing, and the JTEC Auto World Subscription is FREE of Charge. 

JTEC Provides the tools necessary allowing consumers, both buyers and sellers, to make educated decisions, having confidence in their buy/sell transactions. The seamless process continues with additional consumer resources, including a vast nationwide database of auto finance companies, offering pre-approved and on-the-spot financing and top auto insurance providers to compete for the consumers business. 

NEW/USED PARTS

JTEC Auto World’s “New and Used Auto Parts and Accessories” is where a user can look up new or used parts and accessories for their vehicle and compare prices between them.  Individuals, Salvage Yards, Mechanics, anyone can open an account and list any part they may have. A user simply must become a registered subscriber, and then they may buy or sell any new or used car, part, or any automotive product they may have for sale. 

NEW PARTS CATALOG

JTEC’s New Auto Parts E-Catalog System, provided by Epicor, features over 12-million-part numbers with an excess of 13,000 manufacturer lines. Epicor’s PartExpert software is the aftermarket’s most complete and accurate database of replacement parts and related products for cars, light trucks, and medium-duty trucks available today. This world-class software features unparalleled coverage of domestic and foreign makes and models from 1962 to the current year and is referenced in more than 70 percent of all aftermarket part sales in North America. 

USED PARTS CATALOG

JTEC’s Used Auto Parts E-Catalog System will feature a custom designed software program that incorporates a part -locating system, networking auto recyclers, salvage yards, Insurance companies and retailers throughout the United States, Canada, and Mexico.  JTEC will incorporate the use of Hollander’s EDEN software that will provide users with access to more than 194 million used parts from a trusted network of providers allowing JTEC the ability to display this massive inventory of used parts and accessories to a wide and diverse audience.

NATIONAL AUTO TECHNICIAN DIRECTORY

JTEC’s Automotive Technician and Services Directory is a digital marketplace focused on connecting car owners with local service professionals in the automotive industry. From auto repair and service mechanics, body shops, custom shops, wrapping and detailing providers, mobile mechanics and so much more. JTEC Auto World provides seamless access to any service provider a vehicle owner might require or desire. JTEC’s evolving concept is similar to many well-known HOME REPAIR service and advisor platforms, with reviews and ratings, and will be seamlessly integrated with JTEC’s Automobile and Parts business segments. 

Continuing with JTEC’s seamless one-stop experience, the research tools incorporated in the Auto Technician and Services Directory will provide users the opportunity to learn about average repair costs, common installation problems, vehicle/part dependability and recommended service solutions. Additionally, consumers will have access to prescreened available warranties, extended warranties, and other services.

About MasterBeat Corp.

MasterBeat Corporation (OTC: MSTO), incorporated under the laws of Delaware, is a publicly traded company specializing in hard, tangible asset acquisitions with an intense focus on real estate, precious metals, and other tangible assets. The company believes its progressive approach to an old school model, especially in this market based on fragile earnings multiples and uncertainty, to acquire hard, tangible assets will not only offer long term capital appreciation but also deliver revenues, profits, and self-sustainability.

www.masterbeatcorp.com

[email protected]

Safe Harbor Statement

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations and assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Some of these uncertainties include, without limitation, the company’s ability to perform under existing contracts or to procure future contracts. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including without limitation, successful implementation of our business strategy and competition, any of which may cause actual results to differ materially from those described in the statements. We undertake no obligation and do not intend to update, revise or otherwise publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of any unanticipated events. Although we believe that our expectations are based on reasonable assumptions, we can give no assurance that our expectations will materialize. Many factors could cause actual results to differ materially from our forward-looking statements.

Contact:

Josh Tannariello

561-570-7050

[email protected]

CARLSBAD, Calif., March 15, 2021 (GLOBE NEWSWIRE) — Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today the launch of the InVictus^® Occipital-Cervical-Thoracic (OCT) Spinal Fixation System, which extends the sophistication of the InVictus Posterior Fixation Platform to the entire spine.  The InVictus System is engineered to provide adaptable, predictable surgical treatment of a range of pathologies through open, MIS, or hybrid approaches.

“The speed by which we have created and fully launched a comprehensive occiput-to-ilium fixation system with InVictus is unprecedented,” said Pat Miles, Chairman and Chief Executive Officer. “In less than two years, ATEC has orchestrated, from design to commercialization, the largest system our teams have ever released. This speaks to the prowess of the Organic Innovation Machine. With the release of InVictus OCT, we are obviating the last of the legacy Alphatec products and can now offer a clinically distinct platform capable of seamlessly treating the entire spine.”

The first new product to launch within ATEC’s posterior cervical portfolio, InVictus OCT minimizes potential tulip splay and cross-threading, utilizing helical flange technology. The system uniquely gives surgeons the option of utilizing single- or dual-rod tulips to create multi-rod constructs that cross the occipito-cervical junction with increased biomechanical stability. To address the challenges commonly associated with crossing the cervico-thoracic junction, the system features multiple favored-angle screws, a variety of rod-to-rod connectors and seamlessly integrating transition rods. To enhance predictability and optionality, the system is fully compatible with the SafeOp^TM Neural InformatiX System, Arsenal^® Spinal Fixation System, and the InVictus Spinal Fixation System.

“The commercial release of InVictus OCT cements ATEC as the emerging leader in spine,” affirmed Dr. Timothy Kuklo, principal spine surgeon and co-director at the Denver International Spine Center at Presbyterian / St. Luke’s Medical Center. “InVictus OCT extends the InVictus Posterior Fixation System, creating a single system that can address the entire spine from occiput to ilium with the familiar and consistent instrument design, color coding, and nomenclature that surgeons have become accustomed to through the InVictus Thoracolumbar systems. Expertly designed for ease of use, InVictus OCT offers a thread design that simplifies screw insertion, visual and tactile feedback, proximal thoracic transition options and a 4-rod occipital module.  ATEC has clearly developed a best-in-class occipital-cervical solution.”

Key Features of the InVictus OCT Spinal Fixation System 

• Integrates with SafeOp Neural InformatiX System to predictability provide surgeons with real-time, actionable information to detect and monitor the health of nerves at risk during posterior fixation
• Adapts intraoperatively to surgical requirements with robust instruments and customizable implants designed to accept multiple rod diameters and materials, which enables the treatment of more advanced pathologies
• Offers multiple favored-angle screws, a variety of rod-to-rod connectors, and transition rods that work in combination to facilitate crossing the cervico-thoracic junction
• Integrates with InVictus Spinal Fixation System to achieve additional levels of fixation

About Alphatec Holdings, Inc.

Alphatec Holdings, Inc. (ATEC), through its wholly-owned subsidiaries, Alphatec Spine, Inc. and SafeOp Surgical, Inc., is a medical device company dedicated to revolutionizing the approach to spine surgery through clinical distinction. ATEC’s Organic Innovation Machine is focused on developing new approaches that integrate seamlessly with the SafeOp Neural InformatiX System to safely and reproducibly treat spine’s various pathologies and achieve the goals of spine surgery. ATEC’s vision is to become the Standard Bearer in Spine. For more information, visit us at www.atecspine.com.

Forward Looking Statements 

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management’s current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The Company cautions investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors. Forward-looking statements include references to planned commercial launches, product introduction and surgeon adoption and the Company’s strategy in significantly repositioning the ATEC brand. Important factors that could cause actual results to differ significantly from those expressed or implied by such forward-looking statements include, but are not limited to: the uncertainty of success in developing new products or products currently in the Company’s pipeline and the commercial success of such products; failure to achieve acceptance of the Company’s products by the surgeon community; and failure to obtain FDA or other regulatory clearance or approval for new products, or unexpected or prolonged delays in the process. The words “believe,” “will,” “should,” “expect,” “intend,” “estimate,” “look forward” and “anticipate,” variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. A further list and description of these and other factors, risks and uncertainties can be found in the Company’s most recent annual report, and any subsequent quarterly and current reports, filed with the Securities and Exchange Commission. ATEC disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law. 

Investor/Media Contact:

Tina Jacobsen, CFA
Investor Relations
(760) 494-6790
[email protected]

Company Contact:

Jeff Black
Chief Financial Officer  
[email protected]